{"article": [{"url": "https://stocknews.com/news/qure-dont-miss-this-trade-in-uniqure-nv-qure/", "published": 1599653300.0, "headline": "Don\u2019t Miss This Trade in uniQure NV (QURE)", "body": "A key support level has formed in the chart of uniQure NV (QURE). A trade below this level could cause a breakdown in the stock. QURE is a gene therapy company. It develops treatment for patients suffering from genetic and other devastating diseases. The company just started clinical trials of a gene therapy for Huntington\u2019s disease. If the gene therapy succeeds, it could mean a $7 billion annual market for QURE. Take a look at the 1-year chart of QURE with the added notations: 9 \"BUY THE DIP\" Growth Stocks For 2020 Chart of QURE provided by TradingView During the course of the past year, QURE has repeatedly tested the $37 area (green). Just last week the stock traded near this key level, only to bounce higher. If the stock were to break below $37, it is expected a breakdown would occur, leading to much lower prices. Therefore, a trader could enter a short position if the $37 support level is crossed. Want to Discover More Great Trades? I have explored virtually every flavor of technical analysis and chart pattern known to mankind. The sad fact is that the vast majority of them don\u2019t work at all. That is why I recently put together this special report to help investors focus on the only 5 chart patterns that matter\u2026the ones that lead to the most timely and profitable stock trades. Click below to get your copy now! 5 WINNING Stock Chart Patterns Have a good trading day! Good luck! Christian Tharp, CMT @cmtstockcoach QURE shares were trading at $40.25 per share on Wednesday morning, up $0.21 (+0.52%). Year-to-date, QURE has declined -43.83%, versus a 5.97% rise in the benchmark S&P 500 index during the same period."}]}